These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 2054318)

  • 1. 5-fluorouracil, ifosfamide and mitomycin (FIM) combination for pancreatic-biliary tumors.
    Abad A; Rosell R; Barnadas A; Carles J; Ribelles N; Solano V
    Ann Oncol; 1991 Feb; 2(2):153. PubMed ID: 2054318
    [No Abstract]   [Full Text] [Related]  

  • 2. Comparison of 5-fluorouracil, doxorubicin and mitomycin C with 5-fluorouracil alone in the treatment of pancreatic-biliary carcinomas.
    Takada T; Kato H; Matsushiro T; Nimura Y; Nagakawa T; Nakayama T
    Oncology; 1994; 51(5):396-400. PubMed ID: 8052479
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of 5-fluorouracil and leucovorin in the treatment of pancreatic-biliary tract adenocarcinomas.
    Choi CW; Choi IK; Seo JH; Kim BS; Kim JS; Kim CD; Um SH; Kim JS; Kim YH
    Am J Clin Oncol; 2000 Aug; 23(4):425-8. PubMed ID: 10955877
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MIFA III (mitomycin-C, 5-fluorouracil, and adriamycin) chemotherapy for advanced adenocarcinoma of the pancreas.
    Sternberg CN; Magill GB; Sordillo PP; Cheng EW
    Am J Clin Oncol; 1984 Oct; 7(5):529-33. PubMed ID: 6391145
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activity of 5-fluorouracil, mitomycin C, and methyl CCNU in inoperable adenocarcinoma of pancreas.
    Vaughn C; Chapman J; Chinn B; Ward D; Groshko G; Maniscalco B; Reznik S; Piper D
    Am J Clin Oncol; 1989 Feb; 12(1):49-52. PubMed ID: 2492142
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Prospective randomized trial comparing modified FAM (5-fluorouracil (5-FU) + adriamycin + mitomycin C) versus 5-FU alone for the treatment of non-resectable pancreatic and biliary tract carcinomas (the 1st trial in non-resectable patients). Study Group of Surgical Adjuvant Therapy for Carcinomas of the Pancreas and Biliary Tract].
    Takada T; Kato H; Sasaki M; Matsushiro T; Yamauchi H; Kajihara T; Watanabe G; Hanaue H; Yoshida K; Shimizu T
    Gan To Kagaku Ryoho; 1992 Aug; 19(9):1295-301. PubMed ID: 1503483
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chemotherapy for advanced pancreatic cancer. A comparison of 5-fluorouracil, adriamycin, and mitomycin (FAM) with 5-fluorouracil, streptozotocin, and mitomycin (FSM).
    Oster MW; Gray R; Panasci L; Perry MC
    Cancer; 1986 Jan; 57(1):29-33. PubMed ID: 2934124
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Response to doxorubicin/methotrexate/fluorouracil in advanced adenocarcinoma of pancreas or biliary tract.
    Pyrhönen S; Valtonen M
    Lancet; 1990 Jul; 336(8707):127. PubMed ID: 1975317
    [No Abstract]   [Full Text] [Related]  

  • 9. [Prospective randomized trial comparing 1/2 FAM (5-fluorouracil (5-FU) + adriamycin + mitomycin C) versus palliative therapy for the treatment of unresectable pancreatic and biliary tract carcinomas (the 2nd trial in non-resectable patients). Japanese Study Group of Surgical Adjuvant Therapy for Carcinomas of the Pancreas and Biliary Tract].
    Takada T; Kato H; Matsushiro T; Nimura Y; Nagakawa T; Nakayama T; Yamauchi H; Ogata Y; Shimada H; Miyakawa S; Yamaguchi A; Sakoda K; Yasuda H; Tsukada K; Yoshida K; Ashida H; Ishikawa Y; Kotoura Y; Kinoshita H; Kajiwara T; Watanabe G; Uchimura M; Funabiki T; Ikeda S; Okada S
    Gan To Kagaku Ryoho; 1996 May; 23(6):707-14. PubMed ID: 8645022
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A phase III trial on the therapy of advanced pancreatic carcinoma. Evaluations of the Mallinson regimen and combined 5-fluorouracil, doxorubicin, and cisplatin.
    Cullinan S; Moertel CG; Wieand HS; Schutt AJ; Krook JE; Foley JF; Norris BD; Kardinal CG; Tschetter LK; Barlow JF
    Cancer; 1990 May; 65(10):2207-12. PubMed ID: 2189551
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phase II studies of drug combinations in advanced pancreatic carcinoma: fluorouracil plus doxorubicin plus mitomycin C and two regimens of streptozotocin plus mitomycin C plus fluorouracil. The Gastrointestinal Tumor Study Group.
    J Clin Oncol; 1986 Dec; 4(12):1794-8. PubMed ID: 2946815
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Capecitabine and celecoxib as second-line treatment of advanced pancreatic and biliary tract cancers.
    Pino MS; Milella M; Gelibter A; Sperduti I; De Marco S; Nuzzo C; Bria E; Carpanese L; Ruggeri EM; Carlini P; Cognetti F
    Oncology; 2009; 76(4):254-61. PubMed ID: 19246950
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Chemotherapy in cancers of the gallbladder and bile ducts].
    Okada S; Okazaki N
    Gan To Kagaku Ryoho; 1991 Jul; 18(8):1269-72. PubMed ID: 2069397
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Combination therapy with lentinan, mitomycin c, 5-fluorouracil and radiation--a case of long-term survival of pancreas cancer after palliative surgery].
    Kunitomo K; Kawahito M; Miura M; Komi N
    Gan To Kagaku Ryoho; 1987 May; 14(5 Pt 1):1342-4. PubMed ID: 2437863
    [No Abstract]   [Full Text] [Related]  

  • 15. Phase II trial of 5-fluorouracil, adriamycin, mitomycin C, and streptozotocin (FAM-S) in pancreatic carcinoma.
    Bukowski RM; Schacter LP; Groppe CW; Hewlett JS; Weick JK; Livingston RB
    Cancer; 1982 Jul; 50(2):197-200. PubMed ID: 6211223
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Treatment of advanced pancreatic cancer with 5-fluorouracil, 4-epidoxorubicin and mitomycin C (FEM II). From the Chemotherapy of Gastrointestinal Tumors Group].
    Verhees S; Flechtner H; Queisser W; Heim ME; Fritz M; Trux F; Edler L
    Onkologie; 1990 Feb; 13(1):50-2. PubMed ID: 1692400
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combination chemotherapy for locally advanced pancreatic cancer: equivalence to external beam irradiation and implication for future management.
    Smith FP; Stablein D; Korsmeyer S; Neefe J; Chun BK; Woolley PV; Schein PS
    J Clin Oncol; 1983 Jul; 1(7):413-5. PubMed ID: 6689426
    [TBL] [Abstract][Full Text] [Related]  

  • 18. FOLFIRI in patients with locally advanced or metastatic pancreatic or biliary tract carcinoma: a monoinstitutional experience.
    Moretto R; Raimondo L; De Stefano A; Cella CA; Matano E; De Placido S; Carlomagno C
    Anticancer Drugs; 2013 Oct; 24(9):980-5. PubMed ID: 23928570
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of locally unresectable carcinoma of the pancreas: comparison of combined-modality therapy (chemotherapy plus radiotherapy) to chemotherapy alone. Gastrointestinal Tumor Study Group.
    J Natl Cancer Inst; 1988 Jul; 80(10):751-5. PubMed ID: 2898536
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Primary treatment of regional and disseminated pancreatic cancer with hexamethylmelamine, mitomycin C and 5-fluorouracil infusion.
    Bruckner HW; Kalman J; Spigelman M; Gorbaty MI; Butwell N; Storch J; McKenna A
    Oncology; 1989; 46(6):366-71. PubMed ID: 2511535
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.